[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.27.4″ custom_margin=”0px||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row admin_label=”row” _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][et_pb_text admin_label=”Text” _builder_version=”4.27.4″ text_font_size=”16px” text_line_height=”1.9em” background_size=”initial” background_position=”top_left” background_repeat=”repeat” custom_margin=”||||false|false” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]<\/p>\n
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a license and distribution agreement with Isologic Innovative Pharmaceuticals Ltd (Isologic) for the commercialisation of Telix\u2019s investigational prostate cancer imaging agent, Illuccix\u2122\u202f(kit for preparation of gallium Ga-68 gozetotide injection), also known as 68Ga-PSMA-11 injection, for the Canadian market.<\/p>\n
Please follow the link for the entiere release<\/p>\n
English:\u00a0<\/span>https:\/\/www.newswire.ca\/news-releases\/telix-and-isologic-sign-license-and-distribution-agreement-for-illuccix-r-for-canada-858971274.html<\/a><\/span><\/p>\n <\/p>\n <\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a license and distribution agreement with Isologic Innovative Pharmaceuticals Ltd (Isologic) for the commercialisation of Telix\u2019s investigational prostate cancer imaging agent, Illuccix\u2122\u202f(kit for preparation of gallium Ga-68 gozetotide injection), also known as 68Ga-PSMA-11 injection, for the Canadian market. Please follow the link […]<\/p>\n","protected":false},"author":1,"featured_media":2890,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":" Telix Pharmaceuticals Limited<\/strong>\u00a0(ASX\u00a0: TLX, Telix, la soci\u00e9t\u00e9) annonce aujourd'hui avoir sign\u00e9 un accord de licence et de distribution avec\u00a0Isologic Innovative Pharmaceuticals Ltd (Isologic)<\/strong>\u00a0pour la commercialisation de l'investigation de Telix\u00a0cancer de la prostate<\/strong>\u00a0agent d'imagerie,\u00a0Illuccix<\/strong>\u00ae<\/sup>\u202f<\/sup>(kit pour la pr\u00e9paration de l'injection de gallium Ga-68 gozetotide), \u00e9galement connu sous le nom de Ga68-PSMA-11 injectable<\/strong>, pour le march\u00e9 canadien.<\/p>\nVeuillez suivre le lien pour l'int\u00e9gralit\u00e9 de la version\n\nAnglais : https:\/\/www.newswire.ca\/news-releases\/telix-and-isologic-sign-license-and-distribution-agreement-for-illuccix-r-for-canada-858971274.html<\/a>\n\n \n\n ","_et_gb_content_width":"","footnotes":""},"categories":[16,13],"tags":[],"class_list":["post-3039","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dans-la-presse","category-nouvelles-isologic"],"_links":{"self":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/posts\/3039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/comments?post=3039"}],"version-history":[{"count":0,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/posts\/3039\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/media\/2890"}],"wp:attachment":[{"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/media?parent=3039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/categories?post=3039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/isologicradiopharm.ca\/en\/wp-json\/wp\/v2\/tags?post=3039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}